Bellicum Pharma Shares Quiet; Traders Circulate European Patent Register For Co.’s ‘METHODS FOR INDUCING PARTIAL APOPTOSIS USING CASPASE POLYPEPTIDES’
https://register.epo.org/application?number=EP19173088&tab=main
Bellicum Secures $35M Via Equity Funding, Posts Interim Data From Early GoCAR-T Cancer Studies
Bellicum will issue pre-funded warrants to purchase up to 20.6 million shares and accompanying warrants to purchase up to 2.06 million shares at a combined unit price of $1.7024. Warrants have an exercise price of $1.69 per share.
54 Biggest Movers From Yesterday
Gainers
Focus Universal Inc. (NASDAQ: FCUV) shares climbed 278% to close at $19.28 on Wednesday. The stock started trading on Nasdaq Capital Market yesterday.
38 Stocks Moving In Wednesday’s Mid-Day Session
Gainers
Focus Universal Inc. (NASDAQ: FCUV) shares jumped 108.2% to $10.62. The stock started trading on Nasdaq Capital Market yesterday.
Bellicum Pharmaceuticals Q2 EPS $(0.22) Up From $(7.81) YoY
Bellicum Pharmaceuticals (NASDAQ:BLCM) reported quarterly losses of $(0.22) per share. This is a 97.18 percent increase over losses of $(7.81) per share from the same period last year.
